161 related articles for article (PubMed ID: 26505361)
1. Effect of NB-UVB on levels of MCP-1 and CCR6 mRNA in patients with psoriasis vulgaris.
Gao ML; Wang AG
Genet Mol Res; 2015 Oct; 14(4):12137-44. PubMed ID: 26505361
[TBL] [Abstract][Full Text] [Related]
2. Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy.
Rateb AA; Fawzi MM; Abdel Hay RM; Mohammed FN; Amr KS
Eur J Dermatol; 2012; 22(4):481-7. PubMed ID: 22531960
[TBL] [Abstract][Full Text] [Related]
3. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
[No Abstract] [Full Text] [Related]
5. Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy.
Khater MH; AbdallaAlhabib S; Elkshishy KA; Khattab FM
J Dermatolog Treat; 2020 Dec; 31(8):758-762. PubMed ID: 31557066
[No Abstract] [Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.
Lynch M; Ahern TB; Timoney I; Sweeney C; Kelly G; Hughes R; Tobin AM; O'Shea D; Kirby B
Trials; 2016 Jan; 17():29. PubMed ID: 26767505
[TBL] [Abstract][Full Text] [Related]
7. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
[TBL] [Abstract][Full Text] [Related]
8. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
9. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
Park KK; Wu JJ; Koo J
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.
Lynch M; Malara A; Timoney I; Vencken S; Ahern T; Awdeh F; Sweeney C; Galligan M; Kelly G; Hughes R; Murad A; Hambly R; O'Shea D; Doran P; Kirby B
Dermatology; 2022; 238(1):140-147. PubMed ID: 33866313
[TBL] [Abstract][Full Text] [Related]
11. Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes.
Rácz E; Prens EP; Kant M; Florencia E; Jaspers NG; Laman JD; de Ridder D; van der Fits L
Br J Dermatol; 2011 Apr; 164(4):838-47. PubMed ID: 21143460
[TBL] [Abstract][Full Text] [Related]
12. Effect of narrow-band UVB phototherapy on soluble cell adhesion molecules in patients with psoriasis vulgaris.
Long JW; Tao J; Pi XM; Wang YY; Tu YT
J Int Med Res; 2010; 38(4):1507-12. PubMed ID: 20926025
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
14. Effect of narrow-band ultraviolet B phototherapy, methotrexate, and combined narrow-band ultraviolet B phototherapy with methotrexate on serum cathelicidin and vitamin D in patients with psoriasis vulgaris.
El-Hamd MA; El Saied ARA; Ahmed SH; Ibrahim HM; Hegazy EM
J Dermatolog Treat; 2022 Feb; 33(1):408-414. PubMed ID: 32297558
[TBL] [Abstract][Full Text] [Related]
15. Role of Lymphocyte Subpopulations in The Immunopathogenesis of Psoriasis and The Effect of Narrow Band UVB Phototherapy on The Immunological Profile of Psoriasis Patients.
Fattouh M; El-Din AN; El-Hamd MA
Egypt J Immunol; 2017 Jan; 24(1):105-117. PubMed ID: 29120583
[TBL] [Abstract][Full Text] [Related]
16. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy.
Pektas SD; Akoglu G; Metin A; Neselioglu S; Erel O
Redox Rep; 2013; 18(5):200-4. PubMed ID: 24020719
[TBL] [Abstract][Full Text] [Related]
18. Narrowband ultraviolet B phototherapy starting and incremental dose in patients with psoriasis: comparison of percentage dose and fixed dose protocols.
Parlak N; Kundakci N; Parlak A; Akay BN
Photodermatol Photoimmunol Photomed; 2015 Mar; 31(2):90-7. PubMed ID: 25377788
[TBL] [Abstract][Full Text] [Related]
19. Epidermal carotenoid levels in vivo of patients with plaque psoriasis: Effects of narrow-band UVB phototherapy.
Darlenski R; Deliyska R; Al-Sadek LT; Hristakieva E; Fluhr JW
Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):111-114. PubMed ID: 33025688
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment.
Erek Toprak A; Ozlu E; Uzuncakmak TK; Yalcınkaya E; Sogut S; Karadag AS
Med Sci Monit; 2016 Apr; 22():1232-7. PubMed ID: 27070789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
